SecBot SecBot
SECBOTREPLAY Home › Report › PTCT

PTCT · Two insiders at PTC Therapeutics sold a total of $459K in open-market…

PTC THERAPEUTICS, INC. · CLUSTER filed Aug 21, 2026 at 17:20 ET

At the news

NEUTRALIMPACT 2/10

CLUSTER filed Aug 21, 2026 at 17:20 ET

Two insiders at PTC Therapeutics sold a total of $459K in open-market sales over a 7-day window. Director Michael Schmertzler sold $389K and EVP/CLO Mark Boulding sold $71K, with Boulding also exercising options. The total value is only ~0.008% of PTCT's $5.9B market cap, making this a trivial cluster by proportionality standards. The sales are routine and non-informative, no bearish signal from this activity.

  • Two insiders sold a combined $459K in open-market sales over 7 days
  • Director Michael Schmertzler sold $389K across multiple trades at ~$72
  • EVP/CLO Mark Boulding sold $71K after exercising options at $25.69
  • Total sales represent ~0.008% of PTCT's $5.9B market cap, trivial

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access